ANGIODYNAMICS INC Quarterly Deferred Income Tax Expense (Benefit) in USD from Q3 2010 to Q3 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Angiodynamics Inc annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q3 2010 to Q3 2023.
- Angiodynamics Inc Deferred Income Tax Expense (Benefit) for the quarter ending August 31, 2023 was -$11.4M, a 1159% decline year-over-year.
- Angiodynamics Inc annual Deferred Income Tax Expense (Benefit) for 2023 was -$7.97M, a 245% decline from 2022.
- Angiodynamics Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$2.31M, a 37.7% increase from 2021.
- Angiodynamics Inc annual Deferred Income Tax Expense (Benefit) for 2021 was -$3.71M, a 22.8% increase from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)